Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

5-fluorouracil, leucovorin, and oxaliplatin with or without docetaxel in elderly (65 years or older) patients with esophagogastric cancer: FLOT65+ trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

(2017) S. Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

(2017) S. Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein

(2012) Ying Zhu et al.   NUCLEIC ACIDS RESEARCH

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

Microribonucleic acids and gastric cancer

(2011) Ying-Yu Ma et al.   CANCER SCIENCE

Clinical Significance of miR-146a in Gastric Cancer Cases

(2011) R. Kogo et al.   CLINICAL CANCER RESEARCH

Chemotherapy in the Treatment of Metastatic Gastric Cancer: Is There a Global Standard?

(2011) Hyunseok Kang et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy

(2011) Ki Hwan Kim et al.   Gastric Cancer

Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

(2011) Xiaohong Zhao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Gastric carcinogenesis

(2011) Jan Bornschein et al.   LANGENBECKS ARCHIVES OF SURGERY

Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways

(2011) Lizao Chen et al.   MOLECULAR THERAPY

MicroRNAs in the Pathogenesis of Cancer

(2011) Francesca Lovat et al.   SEMINARS IN ONCOLOGY

miRNAs in precancerous lesions of the gastrointestinal tract

(2011) Matteo Fassan   WORLD JOURNAL OF GASTROENTEROLOGY

Global Patterns of Cancer Incidence and Mortality Rates and Trends

(2010) A. Jemal et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression

(2010) Qingmin Sun et al.   CANCER SCIENCE

Pulmonary Resection for Metastatic Gastric Cancer

(2010) Clinton D. Kemp et al.   Journal of Thoracic Oncology

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: A review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer

(2010) Debora Landi et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

MicroRNA dysregulation in gastric cancer: a new player enters the game

(2010) W K K Wu et al.   ONCOGENE

Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan

(2010) V Boni et al.   PHARMACOGENOMICS JOURNAL

MicroRNAs: Novel regulators in the hallmarks of human cancer

(2009) Kai Ruan et al.   CANCER LETTERS

microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis

(2009) A. E. Hoffman et al.   CANCER RESEARCH

Glypican 3-expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear-cell, and α-fetoprotein-producing gastric carcinomas

(2009) Tetsuo Ushiku et al.   CANCER SCIENCE

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

Gastric cancer

(2009) Vincenzo Catalano et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma

(2009) Hongwei Zhang et al.   DIGESTIVE DISEASES AND SCIENCES

Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population

(2009) Sheng Peng et al.   DIGESTIVE DISEASES AND SCIENCES

Future perspectives of chemotherapy for advanced gastric cancer

(2009) Atsushi Ohtsu et al.   Gastric Cancer

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2009) Eray Goekkurt et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

(2009) R. M. Simon et al.   JNCI-Journal of the National Cancer Institute

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

(2009) Prasun J Mishra et al.   PHARMACOGENOMICS

The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone

(2009) Sid P Kerkar et al.   Trials

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

(2008) S.-E. Al-Batran et al.   ANNALS OF ONCOLOGY

MicroRNAs in Cancer

(2008) Yong Sun Lee et al.   Annual Review of Pathology-Mechanisms of Disease

Genetic Variations in MicroRNA-Related Genes Are Novel Susceptibility Loci for Esophageal Cancer Risk

(2008) Y. Ye et al.   Cancer Prevention Research

Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

(2008) Salah-Eddin Al-Batran et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy for metastatic gastric cancer: past, present, and future

(2008) Atsushi Ohtsu   JOURNAL OF GASTROENTEROLOGY

MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers

(2008) R Luthra et al.   ONCOGENE